Blood pressure lowering in acute phase of stroke: Latest evidence and clinical implications

Therapeutic Advances in Chronic Disease

Volumn 3, Issue 4, 2012, Pages 163-171

  Patarroyo, Sully Xiomara Fuentes ^a   Anderson, Craig ^b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

Author keywords

Acute stroke; Blood pressure; Clinical trials; Guidelines

Indexed keywords

ALTEPLASE; CANDESARTAN; GLYCERYL TRINITRATE; NICARDIPINE; PLACEBO;

BLOOD CLOT LYSIS; BLOOD PRESSURE REGULATION; BRAIN EDEMA; BRAIN FUNCTION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; LOW DRUG DOSE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SECONDARY PREVENTION; SYSTOLIC BLOOD PRESSURE;

EID: 84868635105     PISSN: 20406223     EISSN: 20406231     Source Type: Journal    
DOI: 10.1177/2040622312450183     Document Type: Review

References (39)

1. Adams H.P. Jr del Zoppo G. Alberts M.J. Bhatt D.L. Brass L. Furlan A. et al. (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association / American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38: 1655–1711.
2. Ahmed N. Wahlgren N. Brainin M. Castillo J. Ford G.A. Kaste M. et al. (2009) Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis: retrospective analysis from Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Register (SITS-ISTR). Stroke 40: 2442–2449.
3. Anderson C.S. Huang Y. Wang J.G. Arima H. Neal B. Peng B. et al. (2008) Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 7: 391–399.
4. Bath P. Chalmers J. Powers W. Beilin L. Davis S. Lenfant C. et al. (2003) International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 21: 665–672.
5. Bath P.M. Cotton D. Martin R.H. Palesch Y. Yusuf S. Sacco R. et al. (2010) Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Stroke 41: 732–738.
6. Broderick J. Connolly S. Feldmann E. Hanley D. Kase C. Krieger D. et al. (2007) Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association / American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 38: 2001–2023.
7. Broderick J.P. Brott T.G. Duldner J.E. Tomsick T. Huster G. (1993) Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 24: 987–993.
8. Brott T. Lu M. Kothari R. Fagan S.C. Frankel M. Grotta J.C. et al. (1998) Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke 29: 1504–1509.
9. Butcher K. Baird T. MacGregor L. Desmond P. Tress B. Davis S. (2004) Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke 35: 1879–1885.
10. Butcher K. Christensen S. Parsons M. de Silva D.A. Ebinger M. Levi C. et al. (2010) Postthrombolysis blood pressure elevation is associated with hemorrhagic transformation. Stroke 41: 72–77.
11. Chapman N. Huxley R. Anderson C. Bousser M.G. Chalmers J. Colman S. et al. (2004) Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke 35: 116–121.
12. Chobanian A.V. Bakris G.L. Black H.R. Cushman W.C. Green L.A. Izzo J.L. Jr et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289: 2560–2572.
13. Davis S.M. Broderick J. Hennerici M. Brun N.C. Diringer M.N. Mayer S.A. et al. (2006) Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 66: 1175–1181.
14. Delgado Almandoz J.E. Yoo A.J. Stone M.J. Schaefer P.W. Goldstein J.N. Rosand J. et al. (2009) Systematic characterization of the computed tomography angiography spot sign in primary intracerebral hemorrhage identifies patients at highest risk for hematoma expansion: the spot sign score. Stroke 40: 2994–3000.
15. Donnan G.A. Fisher M. Macleod M. Davis S.M. (2008) Stroke. Lancet 371: 1612–1623.
16. Dowlatshahi D. Demchuk A.M. Flaherty M.L. Ali M. Lyden P.L. Smith E.E. (2011) Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology 76: 1238–1244.
17. Geeganage C.M. Bath P.M. (2009) Relationship between therapeutic changes in blood pressure and outcomes in acute stroke: a metaregression. Hypertension 54: 775–781.
18. Hacke W. Donnan G. Fieschi C. Kaste M. von Kummer R. Broderick J.P. et al. (2004) Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363: 768–774.
19. Hacke W. Kaste M. Bluhmki E. Brozman M. Davalos A. Guidetti D. et al. (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359: 1317–1329.
20. Hacke W. Kaste M. Fieschi C. von Kummer R. Davalos A. Meier D. et al. (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European–Australasian Acute Stroke Study Investigators. Lancet 352: 1245–1251.
21. Leonardi-Bee J. Bath P.M. Phillips S.J. Sandercock P.A. (2002) Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 33: 1315–1320.
22. Lindley R.I. Wardlaw J.M. Sandercock P.A. Rimdusid P. Lewis S.C. Signorini D.F. et al. (2004) Frequency and risk factors for spontaneous hemorrhagic transformation of cerebral infarction. J Stroke Cerebrovasc Dis 13: 235–246.
23. Mattle H.P. Kappeler L. Arnold M. Fischer U. Nedeltchev K. Remonda L. et al. (2005) Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 36: 264–268.
24. O'Donnell M.J. Xavier D. Liu L. Zhang H. Chin S.L. Rao-Melacini P. et al. (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376: 112–123.
25. Ohwaki K. Yano E. Nagashima H. Hirata M. Nakagomi T. Tamura A. (2004) Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 35: 1364–1367.
26. Paciaroni M. Agnelli G. Corea F. Ageno W. Alberti A. Lanari A. et al. (2008) Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 39: 2249–2256.
27. Qureshi A.I. (2008) Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation 118: 176–187.
28. Qureshi A.I. Ezzeddine M.A. Nasar A. Suri M.F. Kirmani J.F. Hussein H.M. et al. (2007) Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med 25: 32–38.
29. Robinson T.G. Potter J.F. Ford G.A. Bulpitt C.J. Chernova J. Jagger C. et al. (2010) Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol 9: 767–775.
30. Rose G. (1985) Sick individuals and sick populations. Int J Epidemiol 14: 32–38.
31. Sandset E.C. Bath P.M. Boysen G. Jatuzis D. Korv J. Luders S. et al. (2011) The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 377: 741–750.
32. Strong K. Mathers C. Bonita R. (2007) Preventing stroke: saving lives around the world. Lancet Neurol 6: 182–187.
33. The ENOS Investigators (2006) Glyceryl trinitrate vs. control, and continuing vs. stopping temporarily prior antihypertensive therapy, in acute stroke: rationale and design of the Efficacy of Nitric Oxide in Stroke (ENOS) trial (ISRCTN99414122). Int J Stroke 1: 245–249.
34. Tikhonoff V. Zhang H. Richart T. Staessen J.A. (2008) Blood pressure as a prognostic factor after acute stroke. Lancet Neurol 8: 938–948.
35. Tsivgoulis G. Frey J.L. Flaster M. Sharma V.K. Lao A.Y. Hoover S.L. et al. (2009) Pre-tissue plasminogen activator blood pressure levels and risk of symptomatic intracerebral hemorrhage. Stroke 40: 3631–3634.
36. Wahlgren N. Ahmed N. Eriksson N. Aichner F. Bluhmki E. Davalos A. et al. (2008) Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 39: 3316–3322.
37. Willmot M. Leonardi-Bee J. Bath P.M. (2004) High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 43: 18–24.
38. Yong M. Diener H.C. Kaste M. Mau J. (2005) Characteristics of blood pressure profiles as predictors of long-term outcome after acute ischemic stroke. Stroke 36: 2619–2625.
39. Zhang H. Thijs L. Staessen J.A. (2006) Blood pressure lowering for primary and secondary prevention of stroke. Hypertension 48: 187–195.